No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABT240712C101000
- 3.60
- +0.54+17.65%
15min DelayClose Jul 12 16:00 ET
3.65High3.60Low
3.65Open3.06Pre Close6 Volume91 Open Interest101.00Strike Price2.17KTurnover199.65%IV0.36%PremiumJul 12, 2024Expiry Date3.22Intrinsic Value100Multiplier-1DDays to Expiry0.38Extrinsic Value100Contract SizeAmericanOptions Type0.9369Delta0.0575Gamma31.77Leverage Ratio-3.3048Theta0.0001Rho29.77Eff Leverage0.0013Vega
Intraday
- 5D
- Daily
News
Goldman Sachs, Netflix, Domino's Pizza, TSMC, and More Stocks to Watch This Week -- Barrons.com
By Nicholas Jasinski Second-quarter earnings season will be investors' main focus this week. Around 50 S&P 500 companies are scheduled to report. BlackRock and Goldman Sachs will be Monday's
Financial Stocks Deliver Profits in Q2 Amid Rebound in Investments - Earnings Scorecard
Abbott Laboratories To Go Ex-Dividend On July 15th, 2024 With 0.55 USD Dividend Per Share
July 11th (Eastern Time) - $Abbott Laboratories(ABT.US)$ is trading ex-dividend on July 15th, 2024.Shareholders of record on July 15th, 2024 will receive 0.55 USD dividend per share on August 15th, 20
Here's How Abbott (ABT) Is Placed Ahead of Q2 Earnings Release
The price of West Texas Intermediate (WTI) crude oil is trading at more than the $80 per barrel mark and is likely to remain strong this year.
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
TD Cowen analyst Josh Jennings maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $130.According to TipRanks data, the analyst has a success rate of 52.3%
Comments
$Abbott Laboratories(ABT.US$
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
1
$Abbott Laboratories(ABT.US$
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
2
Morning Movers
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
31
$Abbott Laboratories(ABT.US$
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
2
Read more